Mathieu Simonin

10PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Humoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 22, 2026
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults.

|Feb 18, 2026
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study.

Marlène Pouthier, Nathalie Garnier, Amaury Leruste

|Dec 31, 2025
TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemia.

Estelle Balducci, Thomas Steimlé, Agata Cieslak

|Mar 04, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer.

Guillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy

|Feb 20, 2025
Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL.

Lucien Courtois, Antoine Pinton, Aurélie Cabannes-Hamy

|Jun 07, 2024
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.

Mathieu Simonin, Loïc Vasseur, Etienne Lengliné

Pageof 2

Frequent Collaborators

6 joint publications

Nicolas Boissel

5 joint publications

Guillaume P Andrieu

5 joint publications

Philippe Rousselot

4 joint publications

Vahid Asnafi